Changed Brain Connectivity in Elderly APOE ε4 Carriers: a Whole-brain Voxel-wise Functional Connectivity Strength Analysis
Kai Liu1, Teng Zhang1, Yanjia Deng1, Lin Shi2,3, Defeng Wang4,5, and ADNI Alzheimer’s Disease Neuroimaging Initiative 6

1Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 3Chow Yuk Ho Technology Centre for Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 4Research Center for Medical Image Computing, Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 5Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China, People's Republic of, 6Los Angeles, SC, United States

Synopsis

Apolipoprotein E epsilon 4 allele (APOE-4) is considered as the strongest genetic risk factor for late-onset Alzheimer’s disease, and investigation of its neuropathological effect in normal elderly using advanced neuroimaging connectivity probes has brought much research curiosity. In this study, the underlying abnormal brain connectivity in APOE-4 carriers was analyzed using the functional connectivity strength (FCS), which provides a voxel-wise method to explore the significant connectivity changes at whole-brain level. The results identified APOE-4 related significant connectivity decrease in the bilateral insular and left temporal lobe. We hope these findings could help to shed light on the APOE-4’s neuropathological mechanism.

PURPOSE

This study aims to detect the underlying abnormal functional connectivity strength (FCS) across the whole brain of Apolipoprotein E epsilon 4 allele (APOE-4) carriers.

METHODS

(1) Subjects and grouping: MR data, APOE-4 information, and other demographic information of all the subjects included in this study was acquired from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu, see http://adni.loni.usc.edu/methods/documents/ for detailed inclusion and exclusion information). Genotyping of APOE (including the three genotypes of APOE ε2, ε3, and ε4) was performed using DNA extracted by Cogenics from a 3 ml aliquot of EDTA blood sample. According to whether carry at least one copy of APOE ε4, all the subjects were divided into APOE4+ group (n = 14, including subjects with APOE3/4 and APOE4/4; male/female, 6/8; age, 71.54 ± 3.96 yrs) and APOE4- group (n = 30, including subjects with APOE2/2, APOE2/3, and APOE3/3; male/female, 14/16; age, 74.22 ± 6.35 yrs). (2) MR acquisition and preprocessing: All the subjects were scanned on 3T Philips MRI scanners. The resting-state functional MR images (rs-fMRI) were acquired using the echo-planar imaging (EPI) sequence with the following parameters: TR = 3000 ms, TE = 30 ms, flip angle = 80°, FOV = 212 mm, voxel size = 3.3×3.3×3.3 mm3, 140 time points. Preprocessing of rs-fMRI data was done using the SPM8 (http://www.fil.ion.ucl.ac.uk/spm/). Major steps included slices timing, head motion correction (six-parameter, excluding > 2.0 mm displacement or > 2.0° angular motion), spatial normalization to the MNI space using DARTEL tool, voxel-wise detrending, and regression of white matter signal, cerebrospinal fluid signal, and six motion parameters. (3) FCS calculation: Firstly, The FCS for a single voxel i was calculated as follow:

$$FCS_{voxel}\left(i\right)=\frac{1}{N}\sum_{j\neq i}r_{ij}$$

Where rij represents the Pearson correlation coefficient across the resting-state time series between two voxels of i and j. Negative correlation was excluded due to its biological significance still being unclear, 1 and a threshold of 0.3 was used to exclude the weak correlations (i.e., rij > 0.3 is taken into account). 2 Besides, a mask was constructed (thresholding the whole-group mean gray matter probability map with 0.2) to confine the analysis within grey matter voxels. Finally, the resultant FCS maps were performed with a fisher-Z-transform and spatially smoothed with a Gaussian kernel of 8 mm FWHM before group comparison. (4) Statistical analysis: The differences in demographic and clinical information, including age, education level, mini-mental state examination (MMSE) score, were test using the two-sample T-test (or the Mann-Whitney U-test if normal distribution was not given), and a statistical significant threshold of P < 0.05 was used. FCS maps were compared between APOE+ and APOE- groups using a voxel-wise two-sample T-test. Age and MMSE score were added as covariates to regress out their effects. The statistical significance level was set to P < 0.05 (AlphaSim correction).

RESULTS

Age (P = 0.156, T = 1.44), gender (P = 0.813, Χ2 =0.056), MMSE score (P = 0.370, Z = 0.896), and education level (P = 0.173, Z = 1.362) were matched between groups. Compared with APOE- group, significantly decreased FCS was found in the bilateral insular, right inferior temporal gyrus, right hippocampus, and right cerebellum in the brain of APOE4+ group (P < 0.05, AlphaSim corrected; Table 1, Fig. 1). Besides, no brain region with significantly increased FCS was found in APOE-4 carriers.

DISCUSSION

APOE-4 is currently known as the strongest genetic risk factor for late-onset Alzheimer’s disease (AD), and its related imaging-genetic studies have aroused increasing scientific interests in recent years. Since AD has been widely accepted as one of the most classic neural disconnection syndrome, identification of its genetic cues at the etiology level by using advanced neuroimaging connectivity probes was attempted in normal population by many studies. 3-5 Compared with traditional brain connectivity analysis methods where measurement is among and dependent on a series of region of interest (ROI), voxel-wise FSC analysis calculates the connectivity for each voxel across the whole brain, thus provides a comprehensive and spatially detailed representation for the brain connectivity. According to our results, APOE-4 related significant connectivity decrease was mainly distributed in bilateral insular and right temporal gyrus, both of which were considered as significant victim components under AD status. Therefore, future studies are encouraged to further investigate how these differences could be related to the AD generation and progression.

CONCLUSION

This study identifies APOE-4 related significant connectivity decrease at whole-brain level. We hope the finding could help to shed light on the APOE-4’s neuropathological mechanism.

Acknowledgements

Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The work described in this paper was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No.: CUHK 14113214), a grant from The Science, Technology and Innovation Commission of Shenzhen Municipality (Project No. CXZZ20140606164105361), and the direct grant at CUHK (Project No.: 4054229).

References

1. Weissenbacher A, Kasess C, Gerstl F, et al. Correlations and anticorrelations in resting-state functional connectivity MRI: A quantitative comparison of preprocessing strategies. Neuroimage. 2009;47(4):1408-1416.

2. Liang X, Zou Q, Yang Y. Coupling of functional connectivity and regional cerebral blood flow reveals a physiological basis for network hubs of the human brain. Proc Natl Acad Sci U S A. 2012;110(5):1929-1934.

3. Brown JA, Terashima KH, Burggren AC, et al. Brain network local interconnectivity loss in aging APOE-4 allele carriers. Proc Natl Acad Sci U S A. 2011;108(51):20760-20765.

4. Wolk DA, Dickerson BC, Alzheimer's Disease Neuroimaging Initiative. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010;107(22):10256-10261.

5. Machulda MM, Jones DT, Vemuri P, et al. Effect of APOE epsilon4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol. 2011;68(9):1131-1136.

Figures

Figure 1. Voxel-wise comparison of functional connectivity strength between APOE+ and APOE- groups.

Table 1. Brain regions with significantly different functional connectivity strength between carriers and non-carriers of APOE ε4.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0629